Towards a structural understanding of the mechanism of action of dimeric HCV inhibitors
Hepatitis C Virus (HCV) is expected to be an increasing global healthcare burden. HCV Infection can progress to major chronic hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). No protective vaccine currently exists against hepatitis C and current therapies are ineffective. NS5A is an es...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656403 |